PC(15:0/20:5(5Z,8Z,11Z,14Z,17Z))
|
Basic information |
| Metabolite name | PC(15:0/20:5(5Z,8Z,11Z,14Z,17Z)) |
 | HMDB0007951 |
 |
C00157 |
 |
52922332 |
| Synonyms | NA |
| No. of studies | 2 |
|
Basic information |
| Metabolite name | PC(15:0/20:5(5Z,8Z,11Z,14Z,17Z)) |
| HMDB0007951 |
|
C00157 |
|
52922332 |
| Synonyms | NA |
| No. of studies | 2 |
|
Relationship between PC(15:0/20:5(5Z,8Z,11Z,14Z,17Z)) and depression (count: 2) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M469 | Type1 | Parkinson's disease with depression group vs. Parkinson's disease without depression group | Plasma | Human | Down |
| Study M609 | Type2 | LPS + NBP group vs. LPS group | Hippocampus | Sprague-Dawley rat | Up |